Omega-3 fatty acids and the genetic risk of early onset acute coronary syndrome

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 11, 2014, Pages 1234-1239

  Leung Yinko, S S L ^a,b   Thanassoulis, G ^b,c   Stark, K D ^d   Avgil Tsadok, M ^b   Engert, J C ^a   Pilote, L ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Diet; Genes; Genetics; Lipids; Nutrition

Indexed keywords

OMEGA 3 FATTY ACID;

ACUTE CORONARY SYNDROME; ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 9P; COHORT ANALYSIS; DIETARY INTAKE; FEMALE; GAS CHROMATOGRAPHY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84909630914     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.06.001     Document Type: Article

References (30)

1. Joseph P.G., Pare G., Anand S.S. Exploring gene-environment relationships in cardiovascular disease. Can J Cardiol 2013, 29(1):37-45.
2. Do R., Xie C., Zhang X., Mannisto S., Harald K., Islam S., et al. The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study. PLoS Med 2011, 8(10):e1001106.
3. Lu Y., Feskens E.J., Dolle M.E., Imholz S., Verschuren W.M., Muller M., et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. Am J Clin Nutr 2010, 92(1):258-265.
4. Dwyer J.H., Allayee H., Dwyer K.M., Fan J., Wu H., Mar R., et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 2004, 350(1):29-37.
5. Madden J., Williams C.M., Calder P.C., Lietz G., Miles E.A., Cordell H., et al. The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes. Annu Rev Nutr 2011, 31:203-234.
6. Mozaffarian D., Appel L.J., Van Horn L. Components of a cardioprotective diet: new insights. Circulation 2011, 123(24):2870-2891.
7. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106(21):2747-2757.
8. Kromhout D., Yasuda S., Geleijnse J.M., Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?. Eur Heart J 2012, 33(4):436-443.
9. Mozaffarian D., Wu J.H. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011, 58(20):2047-2067.
10. Bosch J., Gerstein H.C., Dagenais G.R., Diaz R., Dyal L., Jung H., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367(4):309-318.
11. Ness A.R., Ashfield-Watt P.A., Whiting J.M., Smith G.D., Hughes J., Burr M.L. The long-term effect of dietary advice on the diet of men with angina: the diet and angina randomized trial. J Hum Nutr Diet 2004, 17(2):117-119.
12. Roncaglioni M.C., Tombesi M., Avanzini F., Barlera S., Caimi V., Longoni P., et al. n-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013, 368(19):1800-1808.
13. Harris W.S., Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med 2004, 39(1):212-220.
14. Kark J.D., Manor O., Goldman S., Berry E.M. Stability of red-blood-cell membrane fatty-acid composition after acute myocardial-infarction. J Clin Epidemiol 1995, 48(7):889-895.
15. von Schacky C., Harris W.S. Cardiovascular risk and the omega-3 index. J Cardiovasc Med 2007, 8(Suppl. 1):S46-S49.
16. Block R.C., Harris W.S., Reid K.J., Sands S.A., Spertus J.A. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008, 197(2):821-828.
17. Harris W.S., Reid K.J., Sands S.A., Spertus J.A. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007, 99(2):154-158.
18. Pilote L., Karp I. GENESIS-PRAXY (GENdEr and Sex determInantS of cardiovascular disease: from bench to beyond-Premature Acute Coronary SYndrome). Am Heart J 2012, 163(5):741-746 e742.
19. Stark K.D., Salem N. Fast gas chromatography for the identification of fatty acid methyl esters from mammalian samples. Lipid Technol 2005, 17(8):181-185.
20. Metherel A.H., Buzikievich L.M., Charkhzarin P., Patterson A.C., Peel A.C., Howorth A.M., et al. Omega-3 polyunsaturated fatty acid profiling using fingertip-prick whole blood does not require overnight fasting before blood collection. Nutr Res 2012, 32(8):547-556.
21. Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!. Am J Epidemiol 1996, 144(3):207-213.
22. Gatto N.M., Campbell U.B., Rundle A.G., Ahsan H. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. Int J Epidemiol 2004, 33(5):1014-1024.
23. Dennis J., Hawken S., Krewski D., Birkett N., Gheorghe M., Frei J., et al. Bias in the case-only design applied to studies of gene-environment and gene-gene interaction: a systematic review and meta-analysis. Int J Epidemiol 2011, 40(5):1329-1341.
24. Smith G.D., Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol 2003, 32(1):1-22.
25. McPherson R. Chromosome 9p21 and coronary artery disease. N Engl J Med 2010, 362(18):1736-1737.
26. Rivera N.V., Carreras-Torres R., Roncarati R., Viviani-Anselmi C., De Micco F., Mezzelani A., et al. Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes. BMC Med Genet 2013, 14:11.
27. Mozaffarian D., Wu J.H. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?. J Nutr 2012, 142(3):614S-625S.
28. Patterson A.C., Metherel A.H., Hanning R.M., Stark K.D. The percentage of DHA in erythrocytes can detect non-adherence to advice to increase EPA and DHA intakes. Br J Nutr 2014, 111(2):270-278.
29. Metherel A.H., Armstrong J.M., Patterson A.C., Stark K.D. Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 2009, 81(1):23-29.
30. Ordovas J.M. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr 2006, 83(2):443S-446S.